Trade Gilead ^GILD

Nisa Investment Advisors LLC Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Cantor Fitzgerald Comments on Gilead Sciences FY2025 Earnings

Genesis Private Wealth LLC Purchases New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Roberts Wealth Advisors LLC Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Fort Washington Investment Advisors Inc. OH Acquires 53,617 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Is Gilead Sciences (GILD) Among Billionaire Steve Cohen's Top Stock Picks?

Brookmont Capital Management Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Crossmark Global Holdings Inc. Buys 8,741 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Holdings Trimmed by Prairiewood Capital LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Sees Significant Growth in Short Interest

Why Gilead Sciences (GILD) Outpaced the Stock Market Today - January 21, 2025 - Zacks.com

M.E. Allison & CO. Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

HB Wealth Management LLC Purchases 8,406 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Can Gilead Sciences Sustain Its Growth Momentum in 2025? - January 20, 2025 - Zacks.com

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Reduced by Portside Wealth Group LLC

Westend Capital Management LLC Acquires 57,632 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Cohen Klingenstein LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Verity & Verity LLC

Liberty One Investment Management LLC Sells 7,350 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Nexus Investment Management ULC Trims Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Premier Path Wealth Partners LLC Has $744,000 Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Arkadios Wealth Advisors Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Brooklyn Investment Group Has $550,000 Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Position Cut by Cohen Klingenstein LLC

Boston Common Asset Management LLC Sells 53,301 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Avanza Fonder AB Purchases New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

First National Bank of Mount Dora Trust Investment Services Has $406,000 Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Wedge Capital Management L L P NC Sells 86,409 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Park Avenue Securities LLC Buys 6,878 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells $228,375.00 in Stock

Occidental Asset Management LLC Acquires 3,980 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Andrew D. Dickinson Sells 2,500 Shares of Stock

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Ritholtz Wealth Management

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Position Trimmed by Sicart Associates LLC

Gateway Investment Advisers LLC Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences - January 17, 2025 - Zacks.com

Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

Rovin Capital UT ADV Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences CFO sells shares worth $228,375 By Investing.com

USA Financial Formulas Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Assenagon Asset Management S.A. Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Gilead, US end court battle over HIV PrEP patents | BioWorld

D Andrew Dickinson - Insider Monkey

Gilead Sciences Inc. (GILD) - Insider Monkey

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now? - January 16, 2025 - Zacks.com

Allen Mooney & Barnes Investment Advisors LLC Sells 2,205 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, US government settle patent case over HIV prevention drugs By Reuters

Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing - January 15, 2025 - Zacks.com

Global Financial Private Client LLC Boosts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Wright Investors Service Inc. Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

AdvisorNet Financial Inc Sells 336 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

LEO Pharma and Gilead Will Develop STAT6 Program for AD and Other Inflammatory Diseases

Capital Investment Advisors LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

TT International Asset Management LTD Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead and Leo Pharma partner on oral STAT6 program | BioWorld

Other news to note for Jan. 13, 2025 | BioWorld

Gilead, Leo Pharma join in $1.7B deal for STAT6 program | BioWorld

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 ...

Gilead Sciences Inc (GILD) Partners with LEO Pharma to Advance STAT6 Programs for Inflammatory ...

Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD) | Markets Insider

Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters

Gilead, LEO Pharma Enter Strategic Partnership To Accelerate Development Of Oral STAT6 Program | Markets Insider

Morgan Stanley Upgrades Gilead Sciences (NASDAQ:GILD) to "Overweight"

Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com

Morgan Stanley lifts Gilead stock to Overweight on Lenacapavir potential By Investing.com

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by International Assets Investment Management LLC

Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know - January 9, 2025 - Zacks.com

Worth Asset Management LLC Has $828,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors | Morningstar

Nordea Investment Management AB Purchases 45,507 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities | Morningstar

Range Financial Group LLC Acquires 7,868 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Spartan Planning & Wealth Management Purchases New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

RBC keeps Gilead stock at Sector Perform, citing solid HIV foundation By Investing.com

Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPA By Proactive Investors

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Fortem Financial Group LLC

Oliver Luxxe Assets LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Fortem Financial Group LLC

Pensionfund Sabic Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD): A Bull Case Theory

Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors - January 3, 2025 - Zacks.com

Revolutionizing pharma and medical device supply chains with interoperability

Short Interest in Gilead Sciences, Inc. (NASDAQ:GILD) Drops By 6.1%

HIV care | Lenacapavir was the breakthrough drug in 2024

Is Gilead Sciences, Inc. (GILD) the Best Dividend Stock of 2024?

Gilead Sciences (NASDAQ:GILD) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

Rep. Marjorie Taylor Greene Buys Gilead Sciences, Inc. (NASDAQ:GILD) Shares

Is Gilead Sciences, Inc. (GILD) the Best Pharma Dividend Stock to Buy In 2024?

13 Best Pharma Dividend Stocks To Buy In 2024

Jim Cramer on Gilead Sciences, Inc. (GILD): 'I Don't Think The Business Is Worth As Much As The Stock Is Selling'

Assembly Biosciences reports positive phase 1b HBV drug results By Investing.com

In 2024, pandemic breakthroughs were for better and for worse | BioWorld